Nexalin Technology (NASDAQ:NXL) versus LogicMark (OTCMKTS:LGMKD) Financial Analysis

LogicMark (OTCMKTS:LGMKD) and Nexalin Technology (NASDAQ:NXL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Risk and Volatility

LogicMark has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.95, meaning that its share price is 295% more volatile than the S&P 500.

Profitability

This table compares LogicMark and Nexalin Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LogicMark	-90.21%	-57.08%	-44.90%
Nexalin Technology	-4,141.94%	-278.24%	-218.42%

Insider & Institutional Ownership

7.9% of LogicMark shares are held by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are held by institutional investors. 2.2% of LogicMark shares are held by insiders. Comparatively, 16.9% of Nexalin Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares LogicMark and Nexalin Technology”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LogicMark	$9.90 million	0.10	-$9.00 million	($94.52)	-0.01
Nexalin Technology	$300,000.00	11.70	-$8.22 million	($14.41)	-0.33

Nexalin Technology has lower revenue, but higher earnings than LogicMark. Nexalin Technology is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings for LogicMark and Nexalin Technology, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LogicMark	0	1	0	0	2.00
Nexalin Technology	1	0	0	0	1.00

Summary

LogicMark beats Nexalin Technology on 7 of the 12 factors compared between the two stocks.

About LogicMark

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.